A Phase 1-2 clinical trial of EO1001, a novel irreversible pan-ErbB inhibitor with promising brain penetration

Helen Wheeler, Jeffrey Bacha, Sarath Kanekal, Ian Nisbet, Harry Pedersen, Neil Sankar, Wang Shen, Kathy Skoff, Wang Zhen Zhong, Dennis M. Brown

Society for NeuroOncology 2nd Conference on Brain Metastases.  August 2020,  Virtual Conference Event

Leave a Reply

Your email address will not be published. Required fields are marked *